Appleton Partners Portfolio holdings
Appleton Partners is an employee-owned investment firm that specializes in municipal bonds, taxable bonds and stocks for individuals, families and institutions. Douglas Chamberlain co-founded it in 1986 and is its president and chief executive. Before that he was a research director, portfolio manager and trust investment officer. Its custom portfolios serve families, charities and city or state governments. It also manages accounts for other advisers and financial firms. Its investment teams rely on fundamental analysis, backed by economic and technical insights.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.94M |
| 2 |
AGN
Allergan plc
AGN
|
+$3.03M |
| 3 |
Amazon
AMZN
|
+$2.76M |
| 4 |
Broadcom
AVGO
|
+$1.42M |
| 5 |
Dollar Tree
DLTR
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$4.25M |
| 2 |
Citigroup
C
|
+$3.43M |
| 3 |
Under Armour
UAA
|
+$1.91M |
| 4 |
Gilead Sciences
GILD
|
+$1.44M |
| 5 |
Roper Technologies
ROP
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.85% |
| 2 | Financials | 15.07% |
| 3 | Technology | 13.59% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Consumer Staples | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Hasbro
HAS
$16.9B
| $6.43M | 1.31% |
76,505
+2,195
| +3% | +$186K |
2016 Q1
1 quarter
|
|
27
Sherwin-Williams
SHW
$86.5B
| $6.4M | 1.31% |
65,391
+2,418
| +4% | +$236K |
2013 Q2
12 quarters
|
|
28
AbbVie
ABBV
$518B
| $6.23M | 1.27% |
100,687
-3,503
| -3% | -$213K |
2013 Q2
12 quarters
|
|
29
Wabtec
WAB
$50B
| $6.15M | 1.26% |
87,623
-4,076
| -4% | -$317K |
2013 Q2
12 quarters
|
|
30
Goldman Sachs
GS
$261B
| $5.93M | 1.21% |
39,896
-1,382
| -3% | -$216K |
2013 Q2
12 quarters
|
|
|
31
Gilead Sciences
GILD
$210B
| $5.61M | 1.15% |
67,236
-16,178
| -19% | -$1.44M |
2013 Q3
11 quarters
|
|
32
iShares Biotechnology ETF
IBB
$11.5B
| $5.49M | 1.12% |
63,960
-14,124
| -18% | -$1.27M |
2013 Q2
12 quarters
|
|
33
SLB Ltd
SLB
$74.4B
| $5.19M | 1.06% |
65,672
-3,812
| -5% | -$292K |
2013 Q2
12 quarters
|
|
34
Intercontinental Exchange
ICE
$97.3B
| $5.13M | 1.05% |
100,260
+5,110
| +5% | +$258K |
2015 Q1
5 quarters
|
|
35
The Kraft Heinz Company
KHC
$28.9B
| $4.97M | 1.02% |
56,217
-1,059
| -2% | -$87.1K |
2015 Q3
3 quarters
|
|
36
Zoetis
ZTS
$33.4B
| $4.95M | 1.01% |
104,235
-3,781
| -4% | -$179K |
2015 Q1
5 quarters
|
|
37
Akamai
AKAM
$11.6B
| $4.84M | 0.99% |
86,593
-13,540
| -14% | -$712K |
2013 Q2
12 quarters
|
|
|
38
Roper Technologies
ROP
$46.7B
| $4.8M | 0.98% |
28,164
-7,605
| -21% | -$1.33M |
2013 Q2
12 quarters
|
|
39
Microsoft
MSFT
$4.05T
| $4.64M | 0.95% |
90,754
+237
| +0.3% | +$12.3K |
2013 Q2
12 quarters
|
|
40
NXP Semiconductors
NXPI
$64.6B
| $4.41M | 0.9% |
56,350
+2,102
| +4% | +$180K |
2015 Q2
4 quarters
|
|
|
41
UnitedHealth
UNH
$356B
| $4.17M | 0.85% |
+29,523
| New | +$3.94M |
2016 Q2
0 quarters
|
|
42
Mondelez International
MDLZ
$84.1B
| $3.92M | 0.8% |
86,070
-3,946
| -4% | -$172K |
2013 Q2
12 quarters
|
|
43
McDonald's
MCD
$199B
| $3.87M | 0.79% |
32,176
-1,045
| -3% | -$131K |
2013 Q2
12 quarters
|
|
44
Carnival Corporation Ltd
CCL
$41.4B
| $3.73M | 0.76% |
84,305
-845
| -1% | -$41.4K |
2015 Q1
5 quarters
|
|
45
Accenture
ACN
$150B
| $3.59M | 0.73% |
31,689
+718
| +2% | +$83.3K |
2013 Q2
12 quarters
|
|
46
Federated Hermes
FHI
$4.8B
| $3.55M | 0.73% |
123,240
-10,090
| -8% | -$309K |
2013 Q4
10 quarters
|
|
|
47
Amazon
AMZN
$2.89T
| $3.43M | 0.7% |
95,980
+81,520
| +564% | +$2.76M |
2015 Q1
5 quarters
|
|
|
CERN
48
DELISTED
Cerner Corp
CERN
| $3.42M | 0.7% |
58,281
-3,281
| -5% | -$183K |
2013 Q2
12 quarters
|
|
49
VeriSign
VRSN
$27.4B
| $3.33M | 0.68% |
38,507
-1,970
| -5% | -$170K |
2013 Q3
11 quarters
|
|
50
Alphabet (Google) Class C
GOOG
$3.52T
| $3.27M | 0.67% |
94,400
-6,120
| -6% | -$220K |
2013 Q2
12 quarters
|
|
Similar funds
Appleton Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Appleton Partners held 214 positions worth $489M, down 3.3% from $506M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Appleton Partners withdrew a net $15M in Q2 2016, closing 10 positions and reducing 123 holdings. Its most notable exit was Perrigo, an estimated $412K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, Appleton Partners opened a new position in UnitedHealth worth $4.17M.
- Appleton Partners's largest Q2 2016 buy was UnitedHealth: 29,523 shares worth $4.17M.
- Appleton Partners added most to Allergan plc in Q2 2016, an estimated $3.03M increase.
- Appleton Partners's biggest Q2 2016 reduction was Aptiv, cutting an estimated $4.25M.
- Appleton Partners fully exited Perrigo in Q2 2016, selling an estimated $412K.
- Appleton Partners's ten largest holdings make up 23% of its $489M portfolio in Q2 2016.
- Appleton Partners opened 8 new positions and closed 10 in Q2 2016.
- Appleton Partners's portfolio value fell 3.3% quarter-over-quarter to $489M.
Based on Appleton Partners's 13F filing for Q2 2016, filed 3 Aug 2016.